Evidence shows that individuals under 18 were more likely to be diagnosed with new-onset diabetes after a COVID-19 infection (MMWR, January 2022).
This did not differentiate between type 1 and type 2 diabetes, however.
In September 2022, The Journal of the American Medical Association (JAMA) published a study that demonstrated an increased risk for pediatric patients to develop T1D with a history of COVID-19 versus their counterparts with other diagnosed respiratory illnesses.
This concerns me as a healthcare provider and an individual with an autoimmune disease.
If your child has recently been diagnosed with SARS-CoV-2, know the symptoms of T1D and have him/her evaluated immediately:
JAMA Netw Open. 2022;5(9):e2233014. doi:10.1001/jamanetworkopen.2022.33014